These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36191556)

  • 1. Efficacy and safety of nitrous oxide for patients with treatment-resistant depression, a randomized controlled trial.
    Yan D; Liu B; Wei X; Ou W; Liao M; Ji S; Peng Y; Liu J; Wu S; Wang M; Ju Y; Zhang L; Li Z; Li L; Zhang Y
    Psychiatry Res; 2022 Nov; 317():114867. PubMed ID: 36191556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial.
    Nagele P; Duma A; Kopec M; Gebara MA; Parsoei A; Walker M; Janski A; Panagopoulos VN; Cristancho P; Miller JP; Zorumski CF; Conway CR
    Biol Psychiatry; 2015 Jul; 78(1):10-18. PubMed ID: 25577164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirical evidence for the neurocognitive effect of nitrous oxide as an adjunctive therapy in patients with treatment resistant depression: A randomized controlled study.
    Liu J; Zhao X; Wei X; Yan D; Ou W; Liao M; Ji S; Peng Y; Wu S; Wang M; Ju Y; Zhang L; Li Z; Liu B; Li L; Zhang Y
    Psychiatry Res; 2023 Aug; 326():115326. PubMed ID: 37390601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain function changes reveal rapid antidepressant effects of nitrous oxide for treatment-resistant depression:Evidence from task-state EEG.
    Shao X; Yan D; Kong W; Sun S; Liao M; Ou W; Zhang Y; Zheng F; Li X; Li L; Hu B
    Psychiatry Res; 2023 Apr; 322():115072. PubMed ID: 36791487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression.
    Nagele P; Palanca BJ; Gott B; Brown F; Barnes L; Nguyen T; Xiong W; Salloum NC; Espejo GD; Lessov-Schlaggar CN; Jain N; Cheng WWL; Komen H; Yee B; Bolzenius JD; Janski A; Gibbons R; Zorumski CF; Conway CR
    Sci Transl Med; 2021 Jun; 13(597):. PubMed ID: 34108247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrous oxide as an adjunctive therapy in major depressive disorder: a randomized controlled double-blind pilot trial.
    Guimarães MC; Guimarães TM; Hallak JE; Abrão J; Machado-de-Sousa JP
    Braz J Psychiatry; 2021; 43(5):484-493. PubMed ID: 33605397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of nitrous oxide in the treatment of major depressive disorder and treatment-resistant major depressive disorder: A systematic review and meta-analysis nitrous oxide in depressive disorders.
    Rech P; Custodio RM; Rodrigues Uggioni ML; Silveira Prestes G; Marçal F; Silveira VP; Dagostin VS; Colonetti T; Rosa MI
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110869. PubMed ID: 37813146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrous oxide analgesia for bone marrow aspiration and biopsy - A randomized, controlled and patient blinded study.
    Kuivalainen AM; Ebeling F; Poikonen E; Rosenberg PH
    Scand J Pain; 2015 Apr; 7(1):28-34. PubMed ID: 29911602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Minocycline on Depressive Symptoms in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
    Hellmann-Regen J; Clemens V; Grözinger M; Kornhuber J; Reif A; Prvulovic D; Goya-Maldonado R; Wiltfang J; Gruber O; Schüle C; Padberg F; Ising M; Uhr M; Friede T; Huber C; Manook A; Baghai TC; Rupprecht R; Heuser I
    JAMA Netw Open; 2022 Sep; 5(9):e2230367. PubMed ID: 36103181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrous oxide (N
    Stewart RM; Wong JWY; Runions KC; Rao P; Moore JK; Davies SR; von Ungern-Sternberg BS; Sommerfield D; Zepf FD
    Trials; 2017 Dec; 18(1):617. PubMed ID: 29273063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of fixed doses of intranasal Esketamine as an add-on therapy to Oral antidepressants in Japanese patients with treatment-resistant depression: a phase 2b randomized clinical study.
    Takahashi N; Yamada A; Shiraishi A; Shimizu H; Goto R; Tominaga Y
    BMC Psychiatry; 2021 Oct; 21(1):526. PubMed ID: 34696742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Fixed Nitrous Oxide and Oxygen Mixture for Analgesia in Children With Leukemia With Lumbar Puncture-induced Pain: A Randomized, Double-blind Controlled Trial.
    Liu Q; Chai XM; Zhang JJ; Wang YL; Wang Y; Gao LL; Dai YL; Gao HX; Zhang TT; Yu JQ; Li YX
    J Pain Symptom Manage; 2019 Jun; 57(6):1043-1050. PubMed ID: 30853549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial.
    McAllister-Williams RH; Anderson IM; Finkelmeyer A; Gallagher P; Grunze HC; Haddad PM; Hughes T; Lloyd AJ; Mamasoula C; McColl E; Pearce S; Siddiqi N; Sinha BN; Steen N; Wainwright J; Winter FH; Ferrier IN; Watson S;
    Lancet Psychiatry; 2016 Feb; 3(2):117-27. PubMed ID: 26727041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and tolerability of inhaled nitrous oxide in major depressive disorder: a systematic review and meta-analysis.
    Qiu Y; Li L; Duan A; Wang M; Xie M; Chen Z; Wang Z
    Psychopharmacology (Berl); 2023 Oct; 240(10):2033-2043. PubMed ID: 37608194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-administered nitrous oxide/oxygen inhalation provides safe and effective analgesia for percutaneous liver biopsy: a randomized placebo-controlled trial.
    Castéra L; Nègre I; Samii K; Buffet C
    Am J Gastroenterol; 2001 May; 96(5):1553-7. PubMed ID: 11374698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A statistical analysis plan for a randomized clinical trial to evaluate the efficacy and safety of ethosuximide in patients with treatment-resistant depression.
    Jiang J; Wang Z; Dong Y; Yang Y; Ng CH; Ma S; Xu Y; Hu H; Hu S
    Medicine (Baltimore); 2019 Aug; 98(31):e16674. PubMed ID: 31374046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial.
    Yang C; Bosker FJ; Li J; Schoevers RA
    BMC Psychiatry; 2018 Sep; 18(1):279. PubMed ID: 30176835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained Mood Improvement with Laughing Gas Exposure (SMILE): Study protocol for a randomized placebo-controlled pilot trial of nitrous oxide for treatment-resistant depression.
    Ladha KS; Lee J; Mattina GF; Pazmino-Canizares J; Wijeysundera DN; Gholamali Nezhad F; Philip K; Tassone VK; Adamsahib F; Bhat V;
    PLoS One; 2024; 19(1):e0297330. PubMed ID: 38241247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo-control study.
    Chen MH; Cheng CM; Gueorguieva R; Lin WC; Li CT; Hong CJ; Tu PC; Bai YM; Tsai SJ; Krystal JH; Su TP
    Neuropsychopharmacology; 2019 Nov; 44(12):2112-2118. PubMed ID: 31421635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression.
    Park LT; Kadriu B; Gould TD; Zanos P; Greenstein D; Evans JW; Yuan P; Farmer CA; Oppenheimer M; George JM; Adeojo LW; Snodgrass HR; Smith MA; Henter ID; Machado-Vieira R; Mannes AJ; Zarate CA
    Int J Neuropsychopharmacol; 2020 Jul; 23(7):417-425. PubMed ID: 32236521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.